How do I buy Jasper Therapeutics (JSPR) stock?

You can purchase shares of Jasper Therapeutics (NASDAQ:JSPR) through any online brokerage.View our list of the best stock brokerages

Who are Jasper Therapeutics (JSPR) competitors?

Other companies in Jasper Therapeutics’s space includes: Galecto Inc (NASDAQ:GLTO), Kezar Life Sciences Inc (NASDAQ:KZR), Evaxion AS (NASDAQ:EVAX), ABVC BioPharma Inc (NASDAQ:ABVC) and Fortress Biotech Inc (NASDAQ:FBIOP).

What is the forecast, or price target, for Jasper Therapeutics (JSPR) stock?

Jasper Therapeutics has a consensus price target of $25.70.

What is the current price for Jasper Therapeutics (JSPR)?

The stock price for Jasper Therapeutics (NASDAQ: JSPR) is $1.54 last updated January 16, 2026 at 7:39 PM EST.

Does Jasper Therapeutics (JSPR) pay a dividend?

There are no upcoming dividends for Jasper Therapeutics.

When is Jasper Therapeutics (NASDAQ:JSPR) reporting earnings?

Jasper Therapeutics does not have any upcoming earnings scheduled.

Is Jasper Therapeutics (JSPR) going to split?

There is no upcoming split for Jasper Therapeutics.

What sector and industry does Jasper Therapeutics (JSPR) operate in?

Jasper Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Jasper Therapeutics (JSPR) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Biotechnology

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cel...

Comments